Clinical Trials Browser

Phase 1 × INDUSTRY × Abituzumab × Clear all

NCT00958477 2017-08-02

A Study to Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer

Phase 1 Completed

26 enrolled 44 charts

Prostatic Neoplasms

NCT00848510 2015-12-14

EMD 525797 in Colorectal and Ovarian Cancer Patients With Liver Metastases

Phase 1 Completed

41 enrolled 18 charts

GastrointestinalGynecologic

Colorectal and Ovarian Cancer Patients With Liver Metastases